Analysed PHARMING GROUP NV - ADR (PHAR:NASDAQ) News Sources
Pharming Group to report first quarter 2026 financial results and provide business update on May 7
23-04-2026
yahoo.com
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
07-05-2026
yahoo.com
Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
07-05-2026
yahoo.com
Pharming Group N.V. Recorded A 21% Miss On Revenue: Analysts Are Revisiting Their Models
11-05-2026
yahoo.com
We Think Pharming Group's (AMS:PHARM) Profit Is Only A Baseline For What They Can Achieve
14-05-2026
yahoo.com
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
22-05-2026
yahoo.com
What is the current price of PHARMING GROUP NV - ADR (PHAR:NASDAQ)?
The current price of PHARMING GROUP NV - ADR (PHAR:NASDAQ) is $12.99.
PHARMING GROUP NV - ADR (PHAR:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHARMING GROUP NV - ADR (PHAR:NASDAQ) since the previous trading day is $-0.67.
PHARMING GROUP NV - ADR (PHAR:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHARMING GROUP NV - ADR (PHAR:NASDAQ) since the previous trading day is -4.9048%.
What is the most recent average sentiment score for PHARMING GROUP NV - ADR (PHAR:NASDAQ)?
The most recent average sentiment score for PHARMING GROUP NV - ADR (PHAR:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for PHARMING GROUP NV - ADR (PHAR:NASDAQ)?
The most recent sentiment for PHARMING GROUP NV - ADR (PHAR:NASDAQ) is .
SEC-8K** Filing Available For PHARMING GROUP NV - ADR (PHAR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.